Eligibility Esophageal Carcinoma NCT00176800

Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00176800

Eligibility Esophageal Carcinoma NCT00176800

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
adenocarcinoma or squamous cell carcinoma
Item
1. histologically confirmed adenocarcinoma or squamous cell carcinoma of the esophagus or gastroesophageal junction
boolean
C0001418 (UMLS CUI [1])
C0279626 (UMLS CUI [2])
C0014871 (UMLS CUI [3])
treatment for the esophageal cance
Item
2. no prior treatment for the esophageal cancer allowed.
boolean
C0087111 (UMLS CUI [1,1])
C0014859 (UMLS CUI [1,2])
thoracic or upper abdominal radiation
Item
3. no prior thoracic or upper abdominal radiation.
boolean
C0851346 (UMLS CUI [1])
disease should be limited to the esophagus
Item
4. disease should be limited to the esophagus and regional lymph nodes. regional lymph nodes are described in section 4.0. however, celiac node enlargement will be acceptable for tumors of the distal esophagus, because they will be included in the radiation field.
boolean
C2063953 (UMLS CUI [1])
single radiation field
Item
5. disease must be able to be encompassed in a single radiation field.
boolean
C1882536 (UMLS CUI [1])
contraindication to surgery
Item
6. no medical contraindication to surgery
boolean
C0852649 (UMLS CUI [1])
administered at the university of michigan medical center
Item
7. all treatment is to be administered at the university of michigan medical center.
boolean
C2347790 (UMLS CUI [1])
karnofsky performance status
Item
8. karnofsky performance status > 70 %.
boolean
C0206065 (UMLS CUI [1])
age
Item
9. age range: 18 - 75 years old.
boolean
C0001779 (UMLS CUI [1])
hematopoetic function
Item
10. adequate baseline hematopoetic function:
boolean
C0018951 (UMLS CUI [1])
platelet count
Item
platelet count equal to or greater than 100,000/mm3 absolute granulocyte count equal to or greater than 1500/mm3 hematocrit equal to or greater than 29% (patients may be transfused to this level)
boolean
C0005821 (UMLS CUI [1])
C0857490 (UMLS CUI [2])
C0518014 (UMLS CUI [3])
organ function
Item
11. adequate baseline organ function :
boolean
C0678852 (UMLS CUI [1])
creatinine clearance
Item
creatinine clearance >/= 60 mls/min bilirubin equal to or less than 1.5 x upper limits of normal ast/alt equal to or less than 2.5 x upper limits of normal
boolean
C0373595 (UMLS CUI [1])
C1557209 (UMLS CUI [2])
C0364051 (UMLS CUI [3])
hearing loss
Item
12. patients with any complaint of hearing loss should be evaluated with an audiogram. the average pure tone average hearing loss from 500-2000hz should not exceed 30 db. if it does, the patient should be warned that further hearing loss may be very noticeable and permanent.
boolean
C3887873 (UMLS CUI [1])
prior malignancy
Item
13. prior malignancy is acceptable if the patient is considered to be cured. in most cases this will mean a 5-year disease-free period. contact the principal investigator for any specific question regarding this requirement.
boolean
C0006826 (UMLS CUI [1])
active infection
Item
14. patients with active infection, serious inter-current medical conditions are ineligible, according to the judgment of the investigators.
boolean
C0009450 (UMLS CUI [1])
C0009488 (UMLS CUI [2])
pregnant or lactating women
Item
15. pregnant or lactating females are not eligible. women of childbearing potential must be using contraception throughout the entire period of treatment.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
informed consent
Item
16. ability to give informed consent.
boolean
C0021430 (UMLS CUI [1])